Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Intra-Cellular Ther (NQ: ITCI ) 80.39 -0.45 (-0.56%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 625,487 Open 81.16 Bid (Size) 80.39 (1) Ask (Size) 84.59 (5) Prev. Close 80.84 Today's Range 79.43 - 82.00 52wk Range 45.50 - 84.89 Shares Outstanding 94,324,313 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News NVIDIA To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Monday July 22, 2024 Via Benzinga A Closer Look at 11 Analyst Recommendations For Intra-Cellular Therapies July 22, 2024 Via Benzinga Performance YTD +14.04% +14.04% 1 Month +13.26% +13.26% 3 Month +11.19% +11.19% 6 Month +15.07% +15.07% 1 Year +32.20% +32.20% More News Read More China's Bilibili And Ollie's Bargain Outlet Were Among 10 Mid Cap Stocks With Biggest Gains In The Last Week (June 16-June 22, 2024): Are They In Your Portfolio? June 23, 2024 Via Benzinga Intra-Cellular Therapies Stock Scores RS Rating Upgrade To 87 June 20, 2024 Via Investor's Business Daily Patterson Companies, Silk Road Medical, Micron, Hewlett Packard Enterprise And Other Big Stocks Moving Higher On Tuesday June 18, 2024 Via Benzinga Where Intra-Cellular Therapies Stands With Analysts June 12, 2024 Via Benzinga Intra-Cellular Therapies' Highlights Successful Data From Second Depression Study June 18, 2024 Via Benzinga Exposures Product Safety Intra-Cellular Therapies Eyes $1.7 Billion Opportunity After Phase 3 Win June 18, 2024 Via Investor's Business Daily The Secret Stock Stash: 3 Overlooked Picks That Belong in Every Portfolio May 30, 2024 Via InvestorPlace Analyst Ratings For Intra-Cellular Therapies May 08, 2024 Via Benzinga ITCI Stock Earnings: Intra-Cellular Therapies Beats EPS, Beats Revenue for Q1 2024 May 07, 2024 Via InvestorPlace 3 Biotech Stocks With Skyrocketing Potential: April 2024 April 24, 2024 Via InvestorPlace The Analyst Verdict: Intra-Cellular Therapies In The Eyes Of 14 Experts April 22, 2024 Via Benzinga How Is The Market Feeling About Intra-Cellular Therapies? April 19, 2024 Via Benzinga 8 Analysts Assess Intra-Cellular Therapies: What You Need To Know April 03, 2024 Via Benzinga Stock Market Sells Off; Taiwan Semi, ASML, Netflix, Tesla In Focus: Weekly Review April 19, 2024 Via Investor's Business Daily Topics Stocks Exposures US Equities Abbott Laboratories, U.S. Bancorp And 3 Stocks To Watch Heading Into Wednesday April 17, 2024 Via Benzinga Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session April 16, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session April 16, 2024 Via Benzinga Intra-Cellular Stock Rallies On Successful Late-Stage Depression Treatment Study April 16, 2024 Via Benzinga UnitedHealth Reports Upbeat Earnings, Joins Cullinan Oncology, Ericsson And Other Big Stocks Moving Higher On Tuesday April 16, 2024 Via Benzinga Topics Stocks Exposures US Equities Intra-Cellular Therapies Inc. (NASDAQ: ITCI) Climbs to New 52-Week High April 16, 2024 Via Investor Brand Network Intra-Cellular Therapies Stock Launches 20% Into Breakout Territory On Depression Test Results April 16, 2024 Via Investor's Business Daily 12 Health Care Stocks Moving In Tuesday's Pre-Market Session April 16, 2024 Via Benzinga 10 Health Care Stocks Whale Activity In Today's Session April 04, 2024 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.